Genomenon Logo 2021 - stacked tag (2)

Genomenon’s AI-driven Genomic Landscapes deliver a profound understanding of the genetic drivers and clinical attributes of any genetic disease, from neurodegenerative and rare diseases to cancer. This data enables Pharma to accelerate target discovery, identify genetic biomarkers for better clinical trial stratification, and develop CDx for regulatory approval.

Team Members

Mike-Klein-bio-circle3-1-circle

Mike Klein

Chief Executive Officer

2021-Bio-for-Website-Mark-Kiel-circle

Mark Kiel, MD, PhD

Founder & Chief Scientific Officer

2021-Bio-for-Website-Dave-Anstey-circle

Dave Anstey

Vice President of Sales & Business Development

Erin_Maccallum_bio-circle

Erin MacCullum

Director of Sales, Pharmaceutical and Biotech